{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:14:21Z","timestamp":1683173661994},"reference-count":17,"publisher":"SLACK, Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:p>ABSTRACT<\/jats:p>\n          <jats:p>Background: There are not much data available on the use of newer a nti meta bol ites as an initial treatment modality in retinoblastoma, or their effect on vitreous seedings and de novo foci, especially in the Indian subcontinent.<\/jats:p>\n          <jats:p>Methods: To evaluate the efficacy of newer agents as induction chemotherapy, 34 tumors in 22 eyes of 19 children with bilateral retinoblastoma were treated with 2 cycles of carboplatin, etoposide, vincristine, and cyclophosphamide; each cycle was of 1 month duration. The tumor response was evaluated at 2 months and adjuvant salvage modalities (ie, cryotherapy, laser, and\/or external beam radiotherapy) were added as needed. The cycles were continued and ophthalmoscopic and ultrasonographic monitorings were performed to determine further tumor response, tumor height regression, effect on vitreous seeds, and other ocular changes.<\/jats:p>\n          <jats:p>Results: Mean tumor height at presentation was 4.2 mm, which regressed to 2.61 mm at 6 months (P=0.000). The biggest tumor to respond was 1 2.5 mm, although smaller multiple tumors regressed better. Adjuvant modalities were used in 28 tumor foci in 16 eyes. A follow up of 6 to 24 months (mean, 12.8\u00b16.21 months), showed complete regression in 12\/34 tumors, partial regression in 15\/34, stable disease in 6\/34, and ? tumor progressed despite all therapy. Results in all 6 eyes with vitreous seeds were most gratifying; at 1 year vitreous seeds disappeared in 4 eyes and showed complete calcification in 2. Fresh new lesions were not seen in any eye with complete response after the first 2 cycles of chemotherapy. Recurrences were nil and complications minor.<\/jats:p>\n          <jats:p>Conclusions: The overall tumor response (complete and partial) of more than 80% indicates that chemoreduction is an effective modality alone and combined with adjuvant salvage modalities. The results with our treatment regime, even in cases with advanced intraocular retinoblastoma, are encouraging.<\/jats:p>\n          <jats:p>Journal of Pediatric Ophthalmology and Strabismus 2002;39:143-150.<\/jats:p>","DOI":"10.3928\/0191-3913-20020501-05","type":"journal-article","created":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T23:23:07Z","timestamp":1547335387000},"page":"143-150","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Induction Chemotherapy in Retinoblastoma, Alone or Combined With Other Adjuvant Modalities"],"prefix":"10.3928","volume":"39","author":[{"given":"S","family":"Ghose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S H M","family":"Nizamuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B K","family":"Mohanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L S","family":"Arya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Thavaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1 . Abramson DH Niksari K Ellsworth RM et al. Changing trends in the management of retinoblastoma: 1951-1965 vs 1966-1980. J Pediatr Ophthalmol Srabismus. 1994:31:32-37.","DOI":"10.3928\/0191-3913-19940101-07"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"2. Abtamsoii DH Chris.opher M Frank AB. Second nonocular tumors in survivors of butterai rednoblasroma. Ophlhalmology. 1998:105:573-580.","DOI":"10.1016\/S0161-6420(98)94006-4"},{"key":"e_1_3_1_4_1","unstructured":"3. Shields JA Shields C. Rctinoblastoma. In: Shields JA. cd. Intraocular Tumors: A Text and Atlas. Philadelphia: WB Saunders; 1992:305-391."},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. White L. Chemotherapy in reti nob lasroma: current therapy and future directions. Am J Pediatric Hemalol Oncol. 1991:13:189-201.","DOI":"10.1097\/00043426-199122000-00016"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Shields CI. De Potier P Himmelsiein BP Shields JA Meadows AT Maris JM. Cnemoretiucrion in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996:1 14:1330-1338.","DOI":"10.1001\/archopht.1996.01100140530002"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Shulli KR. Ranadc S Neglia J. cl al. An increcred relative frequency of reitriobiastoma ai a rural regional referral hospital in Mirai. India. Cancer. 1993;72:282-286.","DOI":"10.1002\/1097-0142(19930701)72:1<282::AID-CNCR2820720149>3.0.CO;2-A"},{"key":"e_1_3_1_8_1","unstructured":"7. Ghosc S Kumar H Chandra Rumar HV Singha U Mohan ER Mobanti BK Talwar D. How far is retinoblastoma (Rb) amenable to cryotherapy? In: Pasticha JK ed. \u00ccndia Ophthalmology Year Book 1997. New Delhi India: Proceedings of die 55th All India Ophthalmoloeical Society Conference; 1997:335-336."},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Himgcrford JL Toma NMG Plowman PN Kingston JE. External beam radiotherapy for relinoblastoma: I. Whole eye technique. BrJ OphthalmoL 1995;79:105-H7.","DOI":"10.1136\/bjo.79.2.109"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"9. Gallic BL Budning A DeBoet G Thiesson JJ Keren G. Vergie Z Ling V Chan HSL. Chemotherapy with focal therapy can cure intraocular rerinoblasroma without radiotherapy. Arch OphthalmoL 1996;! 14:1321-1328.","DOI":"10.1001\/archopht.1996.01100140521001"},{"key":"e_1_3_1_11_1","doi-asserted-by":"crossref","unstructured":"10. Kingsron JE Hungerford JL Madreperla SA Plowman PN. Results or combined chemotherapy and radiotherapy for advanced rctinoblastoma. Arch OphthalmoL 1996; 114:13391343.","DOI":"10.1001\/archopht.1996.01100140539004"},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Mutphree AL Villabianca JC Deegan WF III Sato JK Malogolowldn M Fisher A Parker R Reed E Comet CJ. Chemotherapy plus local treatment in management of intraocular relinoblastoma. Arch OphthalmoL 1996;1 14:1348-1356.","DOI":"10.1001\/archopht.1996.01100140548005"},{"key":"e_1_3_1_13_1","unstructured":"12. Thavaraj V Nizamuddin SHM Singh R Hasib AG Mohanti BK Arya LS. Outcome of retinoblastoma treated with carboplatin and etoposide: a preliminary report. Med Pediatr Oncol. 1998;31(4):330."},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Chan HSL Thorner PS Calile BL. Miihidnig resistant phenotype in retinoblastoma correlates with P-glycoproiein expression. Ophthalmology. 1991;98:425-431.","DOI":"10.1016\/S0161-6420(91)32134-1"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"14. Rubenfeld M Abramson DH Ellsworrh RM Kitchin FD. Unilateral Vs bilateral retinoblastoma. Correlaiion between age at diagnosis and stage of ocular disease. Ophthalmology. 1986;93(8):1016-1019.","DOI":"10.1016\/S0161-6420(86)33629-7"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. Salmonsen PC Ellswonh RM Kitchen FD. The occurrence of new retinoblastomas after treatment. Ophthalmology. 1979;86:837-840.","DOI":"10.1016\/S0161-6420(79)35469-0"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"16. Shields CL Shields JA Needle M Dc Potter P Kheterpal S Hamada A Meadows AT Combined chemorcduction and adjuvant treatment for imraocular relinoblastoma. Ophthalmology. 1997:104:2101-2111.","DOI":"10.1016\/S0161-6420(97)30053-0"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. Madreperla SA Hungerford JL Doughty D Plowman PN. Kingston JE Singh AD. Treatmem of retinohlastoma vitreous base seeding. Ophthalmology. 1998;I05:120-124.","DOI":"10.1016\/S0161-6420(98)91617-7"}],"container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:34:57Z","timestamp":1683088497000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0191-3913-20020501-05"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.3928\/0191-3913-20020501-05"],"URL":"https:\/\/doi.org\/10.3928\/0191-3913-20020501-05","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"value":"0191-3913","type":"print"},{"value":"1938-2405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}